PRKAA1 and ovarian carcinoma: To address this question, TAK1 in OVCA433 was knockdown by shRNA approach, while there was no change in either phospho-AMPKThr172 or total AMPK levels (Fig. 5f), suggesting AMPK is upstream rather than downstream of TAK1 in ovarian cancer cells.